Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer
Emily K. Kleczko(University of Colorado Anschutz Medical Campus), Raphael A. Nemenoff(University of Colorado Anschutz Medical Campus)
Cited by 4
Related Papers
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
|Life Science Alliance|2019|48
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
|npj Precision Oncology|2023|22
An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases
|PLoS ONE|2015|10
Inflammation Promotes Aging‐Associated Oncogenesis in the Lung
|Aging and Cancer|2024|3